# 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

> **NCT05674396** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 108 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Stereotactic body radiotherapy
- **RADIATION:** Traditional Palliation

## Key facts

- **NCT ID:** NCT05674396
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674396, "3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05674396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*